Latest by Larry Buhl
Behind The Government's Lawsuit Over Gilead's Alleged PrEP Patent Infringement.
A report on the research and activist work that led to the federal government taking nearly unprecedented action against the pharmaceutical company.
Descovy and Truvada Are Both Available for PrEP. But What's the Difference?
As Gilead pressures health care providers to switch to the newer drug, here's some information to make sure you can make the best decision for your health.
San Francisco's Meth Task Force Could Protect Progress in HIV Reduction
San Francisco is seeing a rise in ER visits and overdose deaths due to crystal meth use, particularly among African Americans, Latinx, the homeless, and other vulnerable groups.
Three STDs Are at an All-Time High. And Not Because of PrEP or More Risky Sex
While many people want to blame more risky sex and less condom use on the age of PrEP, the real reasons STDs are rising may have more to do with decreasing resources and programs to fight them.
Much Ado About Descovy
While many celebrated the FDA approval of Descovy for PrEP earlier this month, advocates wonder whether it will make biomedical HIV prevention more or less accessible to those most in need.
For PrEP 2-1-1 Dosing, the Information Is Often Bottom Up
While 2-1-1 or "on-demand" pre-exposure prophylaxis (PrEP) has been approved by major public health agencies, doctors still face uncertainty in implementing it.
Advocates Say Young Men of Color Are at Risk of More Like Ed Buck
Race, money, and power seem to be at play in the growing crystal meth epidemic.
We'll Always Have Cuba, Part 2
A delegation of fifteen gay men (mostly) of color spent fifteen days in Cuba collecting and sharing information on innovations in HIV/AIDS treatment and prevention, sexual and gender identity, and the differences in responses to the AIDS crisis betwe...
We'll Always Have Cuba, Part 1
A delegation of fifteen gay men (mostly) of color spent fifteen days in Cuba collecting and sharing information on innovations in HIV/AIDS treatment and prevention, sexual and gender identity, and the differences in responses to the AIDS crisis betwe...